MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1207-1215

  Tang, Jie Ting ^a   Wang, Ji Lin ^a   Du, Wan ^a   Hong, Jie ^a   Zhao, Shu Liang ^a   Wang, Ying Chao ^a   Xiong, Hua ^a   Chen, Hui Min ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BAG 3 PROTEIN; CARRIER PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 345; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79961189334     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr114     Document Type: Article

References (43)

1. Egger,G. et al. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
2. Cho,W.C. (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer, 6, 60.
3. Zanette,D.L. et al. (2007) miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz. J. Med. Biol. Res., 40, 1435-1440.
4. Lawrie,C.H. (2007) MicroRNAs and haematology: small molecules, big function. Br. J. Haematol., 137, 503-512.
5. Griffiths-Jones,S. et al. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158.
6. Lin,S.L. et al. (2006) First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Mol. Psychiatry, 11, 616-617.
7. Van Rooij,E. et al. (2006) A signature pattern of stress-responsive micro-RNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA, 103, 18255-18260.
8. Calin,G.A. et al. (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res., 66, 7390-7394.
9. Iwai,N. et al. (2005) Polymorphisms in human pre-miRNAs. Biochem. Biophys. Res. Commun., 331, 1439-1444.
10. Blenkiron,C. et al. (2007) miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet., 16, R106-R113.
11. Cho,W.C. (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol., 42, 1273-1281.
12. Cho,W.C. (2010) MicroRNAs in cancer-from research to therapy. Biochim. Biophys. Acta, 1805, 209-217.
13. Michael,M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
14. Conway,K.E. et al. (2000) TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res., 60, 6236-6242.
15. Mori,Y. et al. (2006) A genome-wide search identifies epigenetic silencing of somatostatin, tachykimin-1, and 5 other genes in colon cancer. Gastroenterology, 131, 797-808.
16. Díaz,R. et al. (2008) Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer, 47, 794-802.
17. Han,L. et al. (2007) DNA methylation regulates microRNA expression. Cancer Biol. Ther., 6, 1284-1288.
18. Grady,W.M. et al. (2008) Epigenetic silencing of the intronic microRNA hsamiR-342 and its host gene EVL in colorectal cancer. Oncogene, 27, 3880-3888.
19. Lujambio,A. et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res., 67, 1424-1429.
20. Kunej,T. et al. (2011) Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat. Res doi:10.1016/j.mrfmmm.2011.03.008.
21. Weber,B. et al. (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle, 6, 1001-1005.
22. Chen,C. et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res., 33, e179.
23. Livak,K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T))method. Methods, 25, 402-408.
24. Frommer,M. et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89, 1827-1831.
25. Daskalakis,M. et al. (2002) Demethylation of a hypermethylated p15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood, 100, 2957-2964.
26. Schetter,A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocar cinoma. JAMA, 299, 425-436.
27. Slaby,O. et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402.
28. Asangani,I.A. et al. (2008) MicroRNA-21(miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
29. Lanza,G. et al. (2007) mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer, 6, 54.
30. Akao,Y. et al. (2006) MicroRNAs 143 and 145 are possible common oncomicroRNAs in human cancers. Oncol. Rep., 16, 845-850.
31. Bandreś,E. et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and nontumoral tissues. Mol. Cancer, 19, 29.
32. Akao,Y. et al. (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29, 903-906.
33. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
34. Xi,Y. et al. (2006) Prognostic values of microRNAs in colorectal cancer. Biomark Insights, 2, 113-121.
35. Toyota,M. et al. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 68, 4123-4132.
36. Akao,Y. et al. (2007) Downregulation of microRNAs-143 and -145 in Bcell malignancies. Cancer Sci., 98, 1914-1920.
37. Fang,J.Y. et al. (2004) Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. Cell Res., 14, 217-226.
38. Lu,X. et al. (2008) Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors. Biochimie, 90, 697-704.
39. Wu,W. et al. (2007) MicroRNA and cancer: current status and prospective. Int. J. Cancer, 120, 953-960.
40. Chang,K.H. et al. (2010) MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer, 10, 173.
41. Rosati,A. et al. (2007) Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int. J. Biochem. Cell Biol., 39, 1337-1342.
42. Iwasaki,M. et al. (2007) BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res., 67, 10252-10259.
43. Jacobs,A.T. et al. (2009) HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J. Biol. Chem., 284, 9176-9183.